Skip to content
Triangle logo TriangleGet started
← Full study record

NCT04971226 · OUTCOME

BCR-ABL1≤1% at Scheduled Data Collection Time Points

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP · Source last updated 2026-08-28

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Planned total follow-up duration of 5 years

What was measured

Molecular response is assessed using BCR-ABL transcript levels measured by realtime quantitative polymerase chain reaction.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
anticipated Posting Date
2028-10
denom Units Selected
Participants
description
Molecular response is assessed using BCR-ABL transcript levels measured by realtime quantitative polymerase chain reaction.
reporting Status
NOT_POSTED
time Frame
Planned total follow-up duration of 5 years
title
BCR-ABL1≤1% at Scheduled Data Collection Time Points
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice